Latigo Biotherapeutics, Inc. Listed Unknown
First filed Jul 17, 2026 · CIK 2056611
Effective prospectus: 424B4 Aug 7, 2026 (0001193125-26-340329) · terms unavailable
Offer price
Unavailable
Shares offered
Unavailable
Revenue (FY —)
Not available
Net income (FY —)
Not available
What the company does
No publishable business summary is available from the effective-prospectus read.
Underwriters
Underwriters are unavailable because the effective-prospectus extraction was rejected.
Key risk factors
Risk factors are unavailable because the effective-prospectus extraction was rejected.
Financials before the first trade
The completed SEC companyfacts import produced no qualifying full-year financial history for this filer.
Filing history
| Filed | Form | Accession | |
|---|---|---|---|
| 2026-08-07 | 424B4 | 0001193125-26-340329 | View on EDGAR |
| 2026-08-04 | S-1/A | 0001193125-26-331205 | View on EDGAR |
| 2026-08-03 | S-1/A | 0001193125-26-329431 | View on EDGAR |
| 2026-07-17 | S-1 | 0001193125-26-307306 | View on EDGAR |